HALO News and Press, Halozyme Therapeutics Inc. From 05/28/20

SAN DIEGO , May 28, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley , president and chief executive officer, will be participating in the following investor conferences: Jefferies Virtual Healthcare Conference at 10:00 a.m. E...

SAN DIEGO , May, 14, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced  the company will receive a $15 million milestone payment from Janssen Biotech, Inc. (Janssen) triggered under the Collaboration and License Agreement between the two companies. ...

Biotech Pulse Source: COVID-19 image by Getty Images; edits by PrudentBiotech.com It has taken a pandemic for biotechs to take flight towards their all-time high. One of the first industry groups to recover from the virus-related selloff and be neutral for the year, biotech indexes hav...

The following slide deck was published by Halozyme Therapeutics, Inc. in conjunction with their 2020 Q1 earnings Read more ...

Image source: The Motley Fool. Halozyme Therapeutics Inc   (NASDAQ: HALO) Q1 2020 Earnings Call May 11, 2020 , 4:30 p.m. ET Operator Continue reading

Halozyme Therapeutics, Inc. (HALO) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Al Kildani – Vice President-Investor Relations and Corporate Communications Helen Torley – President and Chief Executive Officer Elaine Sun – Chie...

Gainers: CBAY   +73.4% .   NVAX   +42.9% . YRCW   +39.2% . IIVI   +21.5% . BHF   +13.9% . More news on: CymaBay Therapeutics, Inc., Novavax, Inc., YRC Worldwide Inc., Stocks on the move, , Read more ...

Halozyme Therapeutics (NASDAQ: HALO ): Q1 GAAP EPS of -$0.04 misses by $0.04 . Revenue of $25.3M (-55.5% Y/Y) misses by $17.66M . Shares -7% . Press Release More news on: Halozyme Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,

SAN DIEGO , May 11, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the first quarter ended March 31, 2020 and provided an update on its recent corporate activities and outlook. "This has been a very exciting start to the year fo...

SAN DIEGO , May 7, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), will participate in the Bank of America Securities 2020 Healthcare Conference. This conference is being hosted virtually. Dr. Helen Torley , president and chief executive officer, will provide an overview...